Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Abdominal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00191607
What this trial is testing

Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.

Who this might be right for
Genital Neoplasms, FemaleFallopian Tube NeoplasmsOvarian Neoplasms+2 more
Eli Lilly and Company 162
Not applicableStudy completedNCT05311800
What this trial is testing

High-Intensity Interval Training and Fat Mass Losses

Who this might be right for
Overweight and ObesityMen
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques 9
Testing effectiveness (Phase 2)Ended earlyNCT00903396
What this trial is testing

Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Alliance for Clinical Trials in Oncology 7
Not applicableUnknownNCT04799561
What this trial is testing

Teleprehabilitation for Surgical Cancer Patients

Who this might be right for
Abdominal CancerThoracic Cancer
McGill University Health Centre/Research Institute of the McGill University Health Centre 100
Not applicableStudy completedNCT03152487
What this trial is testing

Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis

Who this might be right for
Pancreatic Carcinoma MetastaticPancreatic AdenocarcinomaPancreatic Neoplasms+2 more
AdventHealth 28
Post-approval studies (Phase 4)Study completedNCT02728921
What this trial is testing

The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery

Who this might be right for
Pancreatic NeoplasmsUrogenital NeoplasmSystemic Inflammatory Response Syndrome+1 more
Region Skane 70
Not applicableWithdrawnNCT02007876
What this trial is testing

Mobility and Activity Training (MAT) to Optimize Outcomes for Older Adult Abdominal Surgery Patients

Who this might be right for
Gastrointestinal Malignancy
University of Michigan
Not applicableStudy completedNCT03064308
What this trial is testing

The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery

Who this might be right for
Impaired CognitionQuality of LifeSurgery+7 more
University of Nottingham 11
Not applicableWithdrawnNCT05338281
What this trial is testing

NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT

Who this might be right for
Breast CancerSurgical Site InfectionWound Dehiscence
Western University, Canada
Testing effectiveness (Phase 2)Active Not RecruitingNCT02571725
What this trial is testing

PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
New Mexico Cancer Research Alliance 50
Early research (Phase 1)Study completedNCT03732768
What this trial is testing

Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis

Who this might be right for
Peritoneal CarcinomatosisOvarian Cancer
Oncoinvent Solutions AS 21
Testing effectiveness (Phase 2)Looking for participantsNCT05500391
What this trial is testing

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

Who this might be right for
Stage I Testicular SeminomaStage I Testicular Nonseminomatous Germ Cell TumorGastrointestinal Stromal Tumors+11 more
Centre Oscar Lambret 88
Not applicableStudy completedNCT05547568
What this trial is testing

A Nomogram to Predict Major Postoperative Complications After Cytoreductive Surgery and HIPEC Based on Pre and Peroperative Criteria: Which Patient Require Intensive Monitoring?

Who this might be right for
Peritoneal Carcinomatosis
CHU de Reims 219
Not applicableStudy completedNCT00780611
What this trial is testing

Investigating the Improvement in 4D CT Images Using AV Biofeedback

Who this might be right for
Cancer of the LungAbdominal Cancer
University of Maryland, Baltimore 25
Not applicableWithdrawnNCT02377492
What this trial is testing

Paracervical Vasopressin Injection Compared With Intramyometrial Vasopressin in Abdominal Myomectomy

Who this might be right for
Myoma
University Hospitals Cleveland Medical Center
Post-approval studies (Phase 4)UnknownNCT05806307
What this trial is testing

Methods Decreasing Bleeding in Open Myomectomy

Who this might be right for
Misoprostol AllergyOxytocin AllergyTranexamic Acid Allergy+3 more
Cairo University 105
Not applicableNot Yet RecruitingNCT07639567
What this trial is testing

Clinical Application Value of Deep Learning-Based "Opportunistic Screening" for Malignant Tumors on Routine Non-Contrast Chest-Abdomen-Pelvis CT

Who this might be right for
Tumor
Lian Yang 100,000
Testing effectiveness (Phase 2)WithdrawnNCT03161041
What this trial is testing

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP Study

Who this might be right for
Colorectal Carcinomatosis
Hospices Civils de Lyon
Early research (Phase 1)Study completedNCT00066456
What this trial is testing

Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaRecurrent Ovarian Carcinoma+2 more
Gynecologic Oncology Group 13
Large-scale testing (Phase 3)Study completedNCT01015118
What this trial is testing

LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsPeritoneal Neoplasms
Boehringer Ingelheim 1,366
Next Page